Oxazep Tablet

About Oxazep 300 mg Tablet

Oxazep is a tablet from Incepta Pharmaceuticals Ltd., with the generic name Oxcarbazepine. Only the doctor can decide whether it suits a particular person and how it should be combined with other treatment.

There are 7 brands of Oxcarbazepine listed in Bangladesh. By unit price, Oxazep is among the cheapest of them.

What is Oxazep 300 mg Tablet?

Made by Incepta Pharmaceuticals Ltd., Oxazep is a tablet whose active ingredient is Oxcarbazepine. Oxazep is a 300 mg extended-release tablet. It is used for partial seizures, either alone or together with other anti-epileptic medicines, in adults and in children. Whether it suits you is a decision for your doctor.

Uses of Oxazep

Only the doctor can decide whether it suits a particular person and how it should be combined with other treatment. Oxazep is used to treat partial seizures.

How to use Oxazep

Take Oxazep exactly as the doctor prescribes. Oxazep is taken by mouth. Swallow the tablet with water. Complete the course exactly as prescribed. Ask your doctor or pharmacist if anything about your schedule is unclear.

Side effects of Oxazep

Common side effects include drowsiness, headache, dizziness, double vision, nausea, vomiting and tiredness. Rarely, the level of sodium in the blood can fall to a level that matters, and allergic reactions such as rash, itching, hives, swelling or a severe reaction can occur. Some people may develop low sodium levels in the blood, which can be serious. Tell your doctor if you notice any side effects, especially if they persist or worsen. Tell your doctor if any side effect bothers you or does not go away.

Safety and precautions

It passes into breast milk, so breastfeeding mothers should ask their doctor. Oxcarbazepine may cause serious birth defects when taken during pregnancy, and it passes into breast milk, so tell your doctor if you are pregnant, planning a pregnancy or breastfeeding. People with kidney problems or known allergy to the ingredients should speak to the doctor before use, and anyone with other health conditions or other medicines should ask the doctor first. Do not stop the medicine suddenly; your doctor will reduce it gradually.

Frequently asked questions

Why is Oxazep prescribed?

Only the doctor can decide whether it suits a particular person and how it should be combined with other treatment. Oxazep is used to treat partial seizures.

How should I take Oxazep?

Take Oxazep exactly as the doctor prescribes. Oxazep is taken by mouth.

What are the side effects of Oxazep?

Common side effects include drowsiness, headache, dizziness, double vision, nausea, vomiting and tiredness. Rarely, the level of sodium in the blood can fall to a level that matters, and allergic reactions such as rash, itching, hives, swelling or a severe reaction can occur.

Can I use Oxazep in pregnancy or while breastfeeding?

It passes into breast milk, so breastfeeding mothers should ask their doctor. Oxcarbazepine may cause serious birth defects when taken during pregnancy, and it passes into breast milk, so tell your doctor if you are pregnant, planning a pregnancy or breastfeeding.

Indications

Oxcarbazepine is indicated for:

Adults: Monotherapy or adjunctive therapy in the treatment of partial seizures

Pediatrics:
  • Monotherapy in the treatment of partial seizures in children 4-16 years
  • Adjunctive therapy in the treatment of partial seizures in children 2–16 years

Pharmacology

The pharmacological activity of Oxcarbazepine is primarily exerted through the metabolite derivative (the monohydroxy derivative, MHD) of Oxcarbazepine. The mechanism of action of Oxcarbazepine and MHD is thought to be mainly based on blockade of voltage-sensitive sodium channels, thus resulting in stabilization of hyper excited neural membranes, inhibition of repetitive neuronal firing and diminishment of propagation of synaptic impulses.

Dosage & Administration

Adults: initiate with a dose of 600 mg/day, given twice-a-day
  • Adjunctive Therapy: Maximum increment of 600 mg/day at approximately weekly intervals. The recommended daily dose is 1200 mg/day
  • Conversion to Monotherapy: withdrawal concomitant over 3 to 6 weeks;reach maximum dose of Oxcarbazepine in 2 to 4 weeks with increments of 600 mg/day at weekly intervals to a recommended daily dose of 2400 mg/day
  • Initiation of Monotherapy: Increments of 300 mg/day every third day to a dose of 1200 mg/day.
  • Creatinine Clearance <30 mL/min: Initiate at one half the usual starting dose and increase slowly
Pediatrics: initiation with 8 to 10 mg/kg/day, given twice-a-day. For patients aged 2 to <4 years and under 20 kg, a starting dose of 16 to 20 mg/kg/day may be considered. Recommended daily dose is dependent upon patient weight.
  • Adjunctive Patients (Aged 2–16 Years): For patients aged 4 to 16 years, target maintenance dose should be achieved over 2 weeks. For patients aged 2 to <4 years, maximum maintenance dose should be achieved over 2 to 4 weeks and should not to exceed 60 mg/kg/day
  • Conversion to Monotherapy for Patients (Aged 4-16 Years): Maximum increment of 10 mg/kg/day at weekly intervals, concomitant antiepileptic drugs can be completely withdrawn over 3 to 6 weeks
  • Initiation of Monotherapy for Patients (Aged 4–16 Years): Increments of 5 mg/kg/day every third day

Interaction

Oxcarbazepine and its metabolite inhibit the enzyme CYP2C19 and therefore, interactions could arise when co-administering high doses of Oxazep with medicinal products that are metabolised by CYP2C19 (e.g. phenobarbital, phenytoin). Concurrent use of Oxazep with hormonal contraceptives may render few contraceptives ineffective (e.g. Ethinylestradiol and Levonorgestrel preparations). Co-administration of Oxazep lowers AUC of felodipine and Verapamil decreases bioavailability of MHD.

Contraindications

It is contraindicated to patients with hypersensitivity to the active substance or to any of the excipients.

Side Effects

The most commonly reported adverse reactions are somnolence, headache, dizziness, diplopia, nausea; vomiting and fatigue. Very rarely clinically significant hyponatraemia can develop during Oxazep use. Class I (immediate) hypersensitivity reactions including rash, pruritus, urticaria, angioedema and reports of anaphylaxis have been received.

Pregnancy & Lactation

Pregnancy: Data on a limited number of pregnancies indicate that Oxcarbazepine may cause serious birth defects (e.g. cleft palate) when administered during pregnancy. In the newborn child. Bleeding disorders in the newborn caused by antiepileptic agents have been reported. As a precaution, vitamin K1 should be administered as a preventive measure in the last few weeks of pregnancy and to the newborn. Oxcarbazepine and its active metabolite (MHD) cross the placenta. Neonatal and maternal plasma MHD concentrations were similar in one case.

Lactation: Oxcarbazepine and its active metabolite (MHD) are excreted in human breast milk. Therefore, Oxazep should not be used during breast-feeding.

Precautions & Warnings

Alcohol: Caution should be exercised if alcohol is taken in combination with Oxazep therapy, due to a possible additive sedative effect.

Withdrawal: As with all antiepileptic medicinal products, Oxazep should be withdrawn gradually to minimise the potential of increased seizure frequency.

Alternative brands of Oxcarbazepine

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.